Locations:
Min Investment:
Max Investment:
Target Investment:
2023
Leading projects in the field of Alzheimer's, contributing to cutting-edge research, innovation, and fostering collaboration in public-private partnerships among Government, Academia, and Pharmaceutical companies.
2022 - 2023
2022 - 2023
2021 - 2023
2021 - 2023
Dolby Family Ventures is an early-stage venture firm focused on building great technology and life sciences companies. The fund honors the legacy of Ray Dolby and his commitment to entrepreneurs and their vision to solve the world’s toughest problems. The life science investments focus on novel neuroscience therapeutics, therapeutics for clinical depression, and neuromodulation/neurostimulation. http://www.dolbyventures.com/
2021 - 2023
2021 - 2023
2019 - 2021
2021 - 2021
2019 - 2021
2017 - 2019
2017 - 2019
Biotechnology and Life Sciences Advising Group (BALSA) Provided market research, technology assessment, competitor analysis, and business plan development for a diverse clientele including startups, universities, and companies.
2014 - 2019
2014 - 2019
▪ Study of the MS4A gene cluster as a key modulator of soluble TREM2 and Alzheimer’s disease risk. ▪ Characterization of the function of the immunoreceptor TREM2 in microglial cells in vitro and in vivo. ▪ Study of the impact of intermittent fasting on a mouse model of multiple sclerosis.
2013 - 2014
2013 - 2014
▪ Study of the relationship between iron and neurodegeneration in neuroferritinophaties. ▪ Study of structural, functional and immunological properties of proteins, with particular attention to the proteins of iron metabolism. ▪ Study of the functional and immunological characteristics of natural ferritins.
2010 - 2013
2010 - 2013
▪ Study of the biological alteration of human primary cells and cell line cultures induced by HIV proteins and its variants. ▪ Study of the biological alteration of human primary cells and cell line cultures induced by herpesvirus-6.
2007 - 2008
2007 - 2008
▪ Assay design of PCR kits for SNPs analysis.